In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and healthy individuals, families, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call.
On December 8-10, Johnson & Johnson Innovation - JLABS and BARDA will virtually convene the emerging Blue Knight community of thought leaders, innovators and entrepreneurs for a three-day symposium, including interactive sessions focused on key areas of interest in infectious disease, public health, and company acceleration. Sessions will explore high priority areas of interest for scientific and technological innovation aimed for improving our preparedness and response to emerging health security threats.
Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, to form Blue Knight. This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases.
The inaugural Blue Knight Symposium will feature three days of interactive programming, including:
· Visionary sessions that will bring together experts in the fields of global health security, preparedness and infectious diseases to discuss lessons learned and priorities for innovations aimed to better protect against known and unknown global health threats.
· Scientific sessions that will focus on key areas of interest for scientific and technological innovation, with each session culminating in a live Q&A.
· Small group discussions that will explore high-priority areas of interest in facilitated breakout sessions with the aim to encourage an active dialogue.